Fig. 3: VHH60 blocks escape mutants and prevailing variants.
From: A broad neutralizing nanobody against SARS-CoV-2 engineered from an approved drug
a VHH60 inhibits pseudovirus carrying spike protein with a single mutation from infecting Caco-2 cell line. b VHH60 inhibits pseudovirus carrying spike protein with multiple mutations as in reported variants from infecting Caco-2 cell line. Error bars represent the means with SDs.
